MERIT MEDICAL SYSTEMS INC
MMSIUS売上高
$1.5B
百万USD
営業利益
$185M
百万USD
純利益
$128M
百万USD
ROE
8.1%
最新FY
EPS
$2.13
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $249M | $11M | $0.19 |
| FY2021 | Q2 | $280M | $5M | $0.09 |
| FY2021 | Q3 | $267M | $12M | $0.21 |
| FY2021 | FY | $1.1B | $48M | $0.84 |
| FY2022 | Q1 | $275M | $11M | $0.18 |
| FY2022 | Q2 | $295M | $15M | $0.27 |
| FY2022 | Q3 | $287M | $15M | $0.27 |
| FY2022 | FY | $1.2B | $75M | $1.29 |
| FY2023 | Q1 | $298M | $21M | $0.36 |
| FY2023 | Q2 | $320M | $20M | $0.35 |
| FY2023 | Q3 | $315M | $26M | $0.44 |
| FY2023 | FY | $1.3B | $94M | $1.62 |
| FY2024 | Q1 | $324M | $28M | $0.48 |
| FY2024 | Q2 | $338M | $36M | $0.61 |
| FY2024 | Q3 | $340M | $28M | $0.48 |
| FY2024 | FY | $1.4B | $120M | $2.03 |
| FY2025 | Q1 | $355M | $30M | $0.49 |
| FY2025 | Q2 | $382M | $33M | $0.54 |
| FY2025 | Q3 | $384M | $28M | $0.46 |
| FY2025 | FY | $1.5B | $128M | $2.13 |
| FY2026 | Q1 | $382M | $41M | $0.68 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $883M | $995M | $964M | $1.1B | $1.2B | $1.3B | $1.4B | $1.5B |
| 営業利益 | $35M | $33M | $59M | $15M | $-2M | $61M | $88M | $124M | $156M | $185M |
| 純利益 | $20M | $28M | $42M | $5M | $-10M | $48M | $75M | $94M | $120M | $128M |
| 総資産 | $943M | $1.1B | $1.6B | $1.8B | $1.7B | $1.6B | $1.7B | $2.3B | $2.4B | $2.7B |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $498M | $676M | $933M | $950M | $959M | $1.0B | $1.1B | $1.2B | $1.4B | $1.6B |
| 営業CF | $54M | $63M | $87M | $78M | $165M | $147M | $114M | $145M | $221M | $297M |
| EPS | $0.45 | $0.55 | $0.78 | $0.10 | $-0.18 | $0.84 | $1.29 | $1.62 | $2.03 | $2.13 |
| BPS | $11.16 | $13.45 | $16.99 | $17.17 | $17.21 | $18.38 | $19.97 | $20.75 | $23.44 | $26.66 |
| ROE | 4.0% | 4.1% | 4.5% | 0.6% | -1.0% | 4.7% | 6.5% | 7.9% | 8.7% | 8.1% |